Market Overview:
The global subcutaneous drug delivery equipment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for self-injection devices, and technological advancements in subcutaneous drug delivery equipment. Based on type, the global subcutaneous drug delivery equipment market is segmented into syringe-based subcutaneous drug delivery, subcutaneous implants, pen systems for subcutaneous drug delivery, auto injectors, and pump-based drug delivery systems. The syringe-based segment is expected to dominate the market during the forecast period owing to its low cost and easy availability. However, the pump-based segment is projected to grow at a higher CAGR due to its advantages such as accurate dosing and reduced medication errors. Based on application, the global subcutaneous drug delivery equipment market is divided into inpatient applications (such as chemotherapy), outpatient applications (such as diabetes management), clinic applications (such as rheumatoid arthritis treatment), and other applications (including veterinary medicine). Inpatient applications are expected to account for a major share of the overall market during 2018–2030 owingtothe growing prevalence of chronic diseases across all regions worldwide.
Product Definition:
Subcutaneous drug delivery equipment are devices that are used to inject drugs or other substances into the subcutaneous tissue, which is located just below the skin. This type of injection is often used to administer medications such as insulin and other types of hormones. The importance of subcutaneous drug delivery equipment lies in its ability to provide a relatively slow and steady release of medication into the bloodstream, which can be helpful for patients who need to control their blood sugar levels or manage other chronic conditions.
Syringe Based Subcutaneous Drug Delivery:
Subcutaneous drug delivery is a technique of delivering drugs by injecting them under the skin. The most common form of SCD is when a drug is injected into the fatty layer just below the skin. This mode of injection allows for higher accuracy and also reduces risks associated with intravenous injections, which are often associated with adverse effects such as infection and blood clotting.
Subcutaneous Implants:
Subcutaneous implants are small-sized devices that are placed under the skin to deliver drugs. They can be used in various applications such as pain management, insulin delivery, and drug monitoring. The subcutaneous implant is a thin silicon wafer or a glass microchip that is embedded under the skin of patients using an adhesive material. It allows for the easy and controlled delivery of drugs through the skin with high accuracy and precision (0.5-1%).
Application Insights:
In-patient application dominated the global market with a revenue share of over 80% in 2017. The need for subcutaneous injections at hospitals to treat various diseases is increasing, which is driving the demand for these devices. According to a study published by NCBI, it was observed that out of total 697 drug formulations, only 39% were used in practice while the remaining 61% were discarded due to lack of efficacy or toxicity. This factor is expected to fuel product demand in near future.
The out-patient segment held a significant share and was valued over USD 200 million in 2017 owing to growing awareness about chronic diseases such as diabetes and obesity coupled with rising incidences of sports injuries requiring SID use for treatment purposes among other patients suffering from musculoskeletal disorders or trauma at outpatient clinics globally.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as favorable reimbursement policies, increasing prevalence of chronic diseases, and technological advancements. Moreover, an increase in the number of clinical trials for new therapies is also expected to drive this regional market over the forecast period. Asia Pacific is expected to grow at a lucrative rate during the forecast period due to factors such as improving healthcare infrastructure and growing target population base. Furthermore, economic development coupled with rising disposable income levels will further boost this growth.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases are responsible for around 63% of all deaths worldwide. This number is expected to increase to 73% by 2030. The growing prevalence of chronic diseases will lead to an increase in demand for subcutaneous drug delivery equipment, as these devices offer a more efficient and convenient way to administer drugs directly into the bloodstream.
- Technological advancements: The subcutaneous drug delivery equipment market is witnessing rapid technological advancements, with new products being launched regularly on the market. These advancements are helping manufacturers improve the accuracy and efficiency of their devices, making them more user-friendly and accessible to a wider audience. Additionally, they are also helping reduce costs, which is likely to result in increased adoption rates over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Subcutaneous Drug Delivery Equipment Market Research Report
By Type
Syringe Based Subcutaneous Drug Delivery, Subcutaneous Implants, Pen Systems for Subcutaneous Drug Delivery, Auto Injectors, Pump Based Drug Delivery Systems
By Application
In-Patient, Out-Patient, Clinic, Others
By Companies
Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, Boehringer Ingelheim
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Subcutaneous Drug Delivery Equipment Market Report Segments:
The global Subcutaneous Drug Delivery Equipment market is segmented on the basis of:
Types
Syringe Based Subcutaneous Drug Delivery, Subcutaneous Implants, Pen Systems for Subcutaneous Drug Delivery, Auto Injectors, Pump Based Drug Delivery Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
In-Patient, Out-Patient, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Eli Lily
- Galaxo
- HMD pharmaceuticals
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Sanofi
- Teva Pharmaceutical
- Boehringer Ingelheim
Highlights of The Subcutaneous Drug Delivery Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Syringe Based Subcutaneous Drug Delivery
- Subcutaneous Implants
- Pen Systems for Subcutaneous Drug Delivery
- Auto Injectors
- Pump Based Drug Delivery Systems
- By Application:
- In-Patient
- Out-Patient
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Subcutaneous Drug Delivery Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Subcutaneous drug delivery equipment is a medical device that helps to deliver medications and other treatments directly to the skin. This type of equipment can be used for a variety of purposes, including delivering medication during surgery or treatment, providing pain relief after surgery, and treating various types of skin conditions.
Some of the key players operating in the subcutaneous drug delivery equipment market are Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, Boehringer Ingelheim.
The subcutaneous drug delivery equipment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Subcutaneous Drug Delivery Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Subcutaneous Drug Delivery Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Subcutaneous Drug Delivery Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Subcutaneous Drug Delivery Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Subcutaneous Drug Delivery Equipment Market Size & Forecast, 2020-2028
4.5.1 Subcutaneous Drug Delivery Equipment Market Size and Y-o-Y Growth
4.5.2 Subcutaneous Drug Delivery Equipment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Syringe Based Subcutaneous Drug Delivery
5.2.2 Subcutaneous Implants
5.2.3 Pen Systems for Subcutaneous Drug Delivery
5.2.4 Auto Injectors
5.2.5 Pump Based Drug Delivery Systems
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 In-Patient
6.2.2 Out-Patient
6.2.3 Clinic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Subcutaneous Drug Delivery Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Subcutaneous Drug Delivery Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Syringe Based Subcutaneous Drug Delivery
9.6.2 Subcutaneous Implants
9.6.3 Pen Systems for Subcutaneous Drug Delivery
9.6.4 Auto Injectors
9.6.5 Pump Based Drug Delivery Systems
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 In-Patient
9.10.2 Out-Patient
9.10.3 Clinic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Syringe Based Subcutaneous Drug Delivery
10.6.2 Subcutaneous Implants
10.6.3 Pen Systems for Subcutaneous Drug Delivery
10.6.4 Auto Injectors
10.6.5 Pump Based Drug Delivery Systems
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 In-Patient
10.10.2 Out-Patient
10.10.3 Clinic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Syringe Based Subcutaneous Drug Delivery
11.6.2 Subcutaneous Implants
11.6.3 Pen Systems for Subcutaneous Drug Delivery
11.6.4 Auto Injectors
11.6.5 Pump Based Drug Delivery Systems
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 In-Patient
11.10.2 Out-Patient
11.10.3 Clinic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Syringe Based Subcutaneous Drug Delivery
12.6.2 Subcutaneous Implants
12.6.3 Pen Systems for Subcutaneous Drug Delivery
12.6.4 Auto Injectors
12.6.5 Pump Based Drug Delivery Systems
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 In-Patient
12.10.2 Out-Patient
12.10.3 Clinic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Syringe Based Subcutaneous Drug Delivery
13.6.2 Subcutaneous Implants
13.6.3 Pen Systems for Subcutaneous Drug Delivery
13.6.4 Auto Injectors
13.6.5 Pump Based Drug Delivery Systems
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 In-Patient
13.10.2 Out-Patient
13.10.3 Clinic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Subcutaneous Drug Delivery Equipment Market: Competitive Dashboard
14.2 Global Subcutaneous Drug Delivery Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Eli Lily
14.3.3 Galaxo
14.3.4 HMD pharmaceuticals
14.3.5 Merck
14.3.6 Novartis
14.3.7 Novo Nordisk
14.3.8 Pfizer
14.3.9 Sanofi
14.3.10 Teva Pharmaceutical
14.3.11 Boehringer Ingelheim
